AlloVir (ALVR) Expected to Announce Earnings on Thursday

AlloVir (NASDAQ:ALVR) is expected to be releasing its earnings data before the market opens on Thursday, March 13th. Analysts expect AlloVir to post earnings of ($2.76) per share for the quarter.

AlloVir Trading Up 1.4 %

NASDAQ:ALVR opened at $9.87 on Friday. AlloVir has a 1 year low of $7.96 and a 1 year high of $24.15. The stock has a market cap of $49.76 million, a price-to-earnings ratio of -0.49 and a beta of 0.63. The stock has a 50-day moving average price of $9.84 and a two-hundred day moving average price of $13.81.

About AlloVir

AlloVir, Inc engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.